Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Enhanced human monocyte cytotoxicity by platelet-activating factor.

F H Valone1, R Philip, R J Debs

  • 1Department of Medicine, VA Medical Center, San Francisco, CA 94143.

Immunology
|August 1, 1988
PubMed
Summary

Platelet-activating factor (PAF) significantly boosts human monocyte cancer cell killing ability, acting through tumor necrosis factor (TNF) to enhance immune responses.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Echocardiography detection rate of newly diagnosed valvular heart disease amongst patients 12 years old and beyond, referred for transthoracic echocardiography in tertiary care settings.

The Medical journal of Malaysia·2025
Same author

A new enigma: doping in E-sports.

The Medical journal of Malaysia·2024
Same author

Effectiveness of nirmatrelvir/ritonavir (Paxlovid®) in preventing hospitalisation and death among COVID-19 patients: a prospective cohort study.

The Medical journal of Malaysia·2023
Same author

Analysis of paediatric cochlear implant candidacy: Single centre, retrospective observational study.

The Medical journal of Malaysia·2022
Same author

Strategies in confronting the COVID-19 pandemic at a tertiary public hospital for Otorhinolaryngology services in Perak, Malaysia.

The Medical journal of Malaysia·2021
Same author

Renal and overall outcomes of double-positive (ANCA and anti-GBM antibodies) patients compared to ANCA-associated vasculitis patients with severe renal involvement: A multicenter retrospective study with systematic renal pathology analysis.

Scandinavian journal of rheumatology·2021

Area of Science:

  • Immunology
  • Cell Biology
  • Biochemistry

Background:

  • Monocytes play a crucial role in the immune system, mediating cellular cytotoxicity.
  • Platelet-activating factor (PAF) is a lipid mediator with diverse biological activities.
  • The precise mechanisms by which PAF influences monocyte-mediated cytotoxicity require further elucidation.

Purpose of the Study:

  • To investigate the effect of Platelet-Activating Factor (PAF) on the cytotoxic activity of human monocytes against WEHI 164 tumor cells.
  • To determine the role of Tumor Necrosis Factor (TNF) in PAF-mediated enhancement of monocyte cytotoxicity.
  • To characterize PAF as a potential modulator of innate immune responses.

Main Methods:

  • Human monocytes were preincubated with varying concentrations of PAF.

Related Experiment Videos

  • Monocyte cytotoxicity was assessed against WEHI 164 cells.
  • The effects of PAF antagonists (kadsurenone) and inactive analogues (lysoPAF, enantioPAF) were evaluated.
  • The involvement of TNF was investigated using anti-TNF antibodies and TNF-resistant cells.

    • Main Results:

    • PAF significantly enhanced monocyte cytotoxicity in a dose-dependent manner, with maximal effects observed between 1 pM and 1 nM.
    • PAF-induced cytotoxicity reached levels comparable to those induced by TNF and interferon-gamma.
    • PAF-induced cytotoxicity was specifically inhibited by kadsurenone and anti-TNF antibodies, but not by inactive PAF analogues.
    • PAF did not enhance cytotoxicity against TNF-resistant cells, indicating TNF-dependency.

    Conclusions:

    • Platelet-activating factor (PAF) is a potent enhancer of human monocyte cytotoxicity against WEHI 164 cells.
    • PAF-mediated enhancement of monocyte cytotoxicity is dependent on the induction of Tumor Necrosis Factor (TNF).
    • PAF represents a distinct class of phospholipid activators that augment cellular immunity through TNF-dependent pathways.